| In millions, except per share items | Jul-31-17 | Jul-31-16 | Jul-31-15 | Jul-31-14 | Jul-31-13 | Jul-31-12 | Jul-31-11 | Jul-31-10 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Medical Imaging | 274.2 | 289.2 | 292.6 | 295.6 | 318.6 | 301.8 | 293.0 | 251.5 |
| United States | 183.5 | 192.3 | 215.3 | 183.8 | 209.6 | 199.5 | 161.7 | 139.5 |
| Ultrasound | 146.9 | 163.2 | 166.2 | 152.5 | 149.8 | 151.2 | 129.4 | 112.7 |
| Other | 108.8 | 126.4 | 153.3 | 135.5 | 114.3 | 110.3 | | 103.4 |
| Total revenues [+] | 486.4 | 508.8 | 540.3 | 517.5 | 550.4 | 516.6 | 473.6 | 414.8 |
| Products | 484.2 | 502.8 | 531.2 | 509.5 | 526.7 | 494.7 | 447.6 | 393.8 |
| Services | 2.2 | 6.1 | 9.1 | 8.0 | 23.6 | 21.9 | 26.0 | 21.0 |
| Revenue growth [+] | -4.4% | -5.8% | 4.4% | -6.0% | 6.5% | 9.1% | 14.2% | 7.2% |
| Medical Imaging | -5.2% | -1.2% | -1.0% | -7.2% | 5.6% | 3.0% | 16.5% | -1.5% |
| United States | -4.6% | -10.7% | 17.1% | -12.3% | 5.1% | 23.4% | 15.9% | -4.5% |
| Ultrasound | -10.0% | -1.8% | 9.0% | 1.8% | -0.9% | 16.8% | 14.8% | 36.5% |
| Other | -13.9% | -17.5% | 13.1% | 18.5% | 3.6% | | | 26.7% |
| Germany | 9.6% | 13.8% | -2.6% | -11.5% | 9.9% | 12.7% | 14.1% | 6.2% |
| Cost of goods sold [+] | 287.1 | 280.8 | 310.8 | 297.8 | 333.7 | 323.4 | 300.6 | 266.9 |
| Cost of product sales | 282.1 | 275.6 | 303.0 | 291.0 | 313.5 | 302.3 | 278.2 | 248.4 |
| Cost of technology services | 5.0 | 5.2 | 7.8 | 6.9 | 20.2 | 21.1 | 22.5 | 18.6 |
| Gross profit | 199.3 | 228.1 | 229.5 | 219.7 | 216.7 | 193.2 | 173.0 | 147.9 |
| Gross margin | 41.0% | 44.8% | 42.5% | 42.5% | 39.4% | 37.4% | 36.5% | 35.7% |
| Selling, general and administrative [+] | 110.9 | 126.1 | 120.8 | 113.3 | 103.8 | 96.0 | 82.0 | 76.7 |
| Sales and marketing | 67.8 | 65.3 | 63.5 | 59.2 | 51.3 | 44.2 | 41.4 | 36.8 |
| General and administrative | 43.1 | 60.8 | 57.3 | 54.1 | 52.5 | 51.8 | 40.6 | 39.9 |
| Research and development | 63.5 | 67.1 | 68.5 | 73.8 | 64.0 | 57.2 | 63.1 | 49.2 |
| Equity in earnings | | | | | | | | |
| EBITDA [+] | 49.5 | 57.8 | 63.6 | 54.6 | 66.2 | 57.7 | 45.6 | 38.8 |
| EBITDA growth | -14.3% | -9.0% | 16.3% | -17.4% | 14.6% | 26.6% | 17.5% | 101.3% |
| EBITDA margin | 10.2% | 11.4% | 11.8% | 10.6% | 12.0% | 11.2% | 9.6% | 9.4% |
| Depreciation | 17.2 | 14.6 | 14.4 | 14.3 | 13.2 | 14.7 | 14.7 | 13.9 |
| EBITA | 32.3 | 43.3 | 49.1 | 40.4 | 53.0 | 43.1 | 30.9 | 24.9 |
| EBITA margin | 6.6% | 8.5% | 9.1% | 7.8% | 9.6% | 8.3% | 6.5% | 6.0% |
| Amortization of intangibles | 7.4 | 8.4 | 8.9 | 7.8 | 4.1 | 3.1 | 3.1 | 2.9 |
| EBIT [+] | 24.9 | 34.9 | 40.2 | 32.6 | 48.9 | 40.0 | 27.8 | 22.0 |
| EBIT growth | -28.5% | -13.4% | 23.6% | -33.4% | 22.3% | 43.7% | 26.3% | 936.7% |
| EBIT margin | 5.1% | 6.8% | 7.4% | 6.3% | 8.9% | 7.7% | 5.9% | 5.3% |
| Non-recurring items [+] | 91.7 | 9.6 | -0.4 | 3.5 | 3.5 | | 7.1 | 0.7 |
| Asset impairment | 84.5 | | | 2.4 | | | | |
| Interest income | | | | 0.3 | 0.4 | 0.5 | 0.7 | 0.6 |
| Interest income | | | | 0.3 | 0.4 | 0.5 | 0.7 | 0.6 |
| Other income (expense), net | 0.5 | -4.9 | 0.4 | -0.3 | -1.6 | 3.7 | -0.5 | -0.5 |
| Pre-tax income | -66.3 | 20.3 | 41.0 | 29.0 | 44.1 | 44.2 | 20.9 | 21.5 |
| Income taxes | 8.0 | 8.2 | 7.6 | -5.4 | 13.0 | 1.1 | 4.3 | 5.7 |
| Tax rate | | 40.3% | 18.4% | | 29.4% | 2.6% | 20.6% | 26.4% |
| Earnings from continuing ops | -74.2 | 12.1 | 33.5 | 34.5 | 31.1 | 43.1 | 16.6 | 15.8 |
| Earnings from discontinued ops | | | | | | | 0.9 | -0.2 |
| Net income | -74.2 | 12.1 | 33.5 | 34.5 | 31.1 | 43.1 | 17.8 | 15.6 |
| Net margin | -15.3% | 2.4% | 6.2% | 6.7% | 5.7% | 8.3% | 3.8% | 3.7% |
| |
| Basic EPS [+] | ($5.96) | $0.98 | $2.70 | $2.78 | $2.54 | $3.51 | $1.33 | $1.26 |
| Growth | -709.5% | -63.8% | -2.9% | 9.4% | -27.6% | 163.9% | 6.0% | 358.2% |
| Diluted EPS [+] | ($5.96) | $0.96 | $2.66 | $2.72 | $2.48 | $3.42 | $1.32 | $1.25 |
| Growth | -720.0% | -63.8% | -2.4% | 9.9% | -27.7% | 159.1% | 5.9% | 359.1% |
| |
| Dividends per share [+] | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 | $0.40 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -0.2% | |
| |
| Shares outstanding (basic) [+] | 12.5 | 12.4 | 12.4 | 12.4 | 12.2 | 12.3 | 12.5 | 12.6 |
| Growth | 0.4% | 0.0% | 0.0% | 1.3% | -0.1% | -1.8% | -0.7% | -2.0% |
| Shares outstanding (diluted) [+] | 12.5 | 12.6 | 12.6 | 12.7 | 12.6 | 12.6 | 12.6 | 12.7 |
| Growth | -1.3% | 0.1% | -0.5% | 0.8% | -0.1% | 0.0% | -0.7% | -2.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |